The Joplin Globe

Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small-Molecule API Manufacturing Capacity in Delaware

Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) ...
PharmiWeb

ESTEVE CDMO Commences $15.5 Million Expansion of Chicago Small Molecule API Facility

BARCELONA, SPAIN – February 26, 2026 – ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a ...
Contract Pharma

IPP Offers Access to API Manufacturing Capacity at Grimsby, UK Site

qualified companies can utilize one or more of three established pharmaceutical manufacturing plants on the campus under a ...
Business Wire

Teva Announces Intention to Divest API Business as Part of Pivot to Growth Strategy

TEL AVIV, Israel--(BUSINESS WIRE)--Teva announced today its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI". TAPI is a global leader in the small-molecule API ...